| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2000;31:140.)
© 2000 American Heart Association, Inc.
Original Contributions |
Presented in part at the 22nd Annual American Society of Neuroimaging Meeting, February 2427, 1999, Scottsdale, Ariz.
From the Center for Noninvasive Brain Perfusion Studies and the Stroke Treatment Team, University of TexasHouston Medical School, Houston, Tex.
Correspondence to Dr A.V. Alexandrov, Department of Neurology, University of TexasHouston Medical School, 6431 Fannin, MSB 7.044, Houston, TX 77030. E-mail avalexandrov{at}worldnet.att.net
| Abstract |
|---|
|
|
|---|
MethodsUsing a standard insonation protocol, we prospectively evaluated the frequency of specific TCD findings in patients with or without proximal extracranial or intracranial occlusion determined by digital subtraction or MR angiography.
ResultsOf 190 consecutive patients studied, angiography showed
occlusion in 48 patients. With proximal internal carotid artery (ICA)
occlusion, TCD showed abnormal middle cerebral artery (MCA) waveforms
(AMCAW) in 66.7%, reversed ophthalmic artery (OA) in 70.6%, anterior
cross-filling via anterior communicating artery (ACoA) in 78.6%,
posterior communicating artery (PCoA) in 71.4%, and contralateral
compensatory velocity increase (CVI) in 84.6% of patients. With distal
ICA occlusion, TCD showed AMCAW in 88.9%, OA in 16.7%, ACoA in 50%,
PCoA in 60%, and CVI in 88.9% of patients. With MCA occlusion, TCD
showed AMCAW in 100%, OA in 23.5%, ACoA in 31.3%, PCoA in 23.1%,
and CVI in 62.5%. With no anterior circulation occlusion at
angiography, TCD showed these parameters in 1.8% to
17.9%,
2 P
0.003.
Parameters localizing anterior circulation occlusion were
stenotic terminal ICA velocities 46% versus 10% in patent
vessels; flow diversion to perforators 73% versus 1.8%; OA 70.6%
versus 5.6%; ACoA 78.6% versus 8.2%; PCoA 71.4% versus 8.5%, all
at P<0.05. In patients with basilar artery (BA)
occlusion, ABAW were found in 80% versus 3% (patent BA); flow
diversion to anterior vessels in 60% versus 5.7%; BA flow reversal in
20% versus 0%; and PCoA in 100% versus 13.7%, all at
P<0.001. No individual parameters
differentiated BA from the terminal vertebral occlusion.
ConclusionsSpecific TCD findings are common with major arterial occlusion and can be used to broaden diagnostic batteries and improve the predictive value of noninvasive screening in stroke patients. TCD findings useful to localize anterior circulation occlusion include collaterals, abnormal waveforms or velocities, and flow diversion to perforators.
Key Words: occlusion stroke ultrasonography, Doppler
| Introduction |
|---|
|
|
|---|
In the present study we aimed to evaluate the frequency of specific TCD flow findings in patients with angiographically proved arterial occlusion. The data on frequency of these flow findings in angiographically positive and negative cases will aid application of diagnostic criteria for TCD and will help develop a role for TCD in future stroke evaluation and treatment. Our secondary goal was to identify TCD flow findings that could help to localize arterial occlusion.
| Subjects and Methods |
|---|
|
|
|---|
Anterior Circulation
Normal ICA, MCA, or ACA Findings11
A low-resistance flow (PI 0.6 to 1.1) with normal flow
direction, age-expected mean flow velocities (MFVs) <80 cm/s,
unilateral velocity ratio MCA
ACA
ICA, and normal systolic
flow acceleration, ie, arrival of maximum velocity during early
systole.
Stenotic Velocities
A significant focal MFV increase of >30% compared with a
neighboring or homologous arterial segment, and/or MCA MFV
80 cm/s, ACA MFV
80 cm/s, and ICA MFV
70 cm/s in adults.
M1 MCA waveforms were determined from 65- to 45-mm depths as unidirectional signals toward the probe; M2 MCA waveforms were obtained from 45- to 35-mm depths as unidirectional or bidirectional signals.
Abnormal ICA, MCA, or ACA Waveforms (Figure 1
)
1. Dampened signal: Pulsatile flow with normal
flow acceleration and decreased MFV (
30% difference between
hemispheres); any PI values.
|
2. Blunted signal: Delayed flow acceleration with
stepwise maximum velocity arrival during mid to late systole compared
with contralateral side and focal decreased MFV and positive
end-diastolic flow (low PI
1.1).
3. Minimal signal: Presence of a flow signal with no
end diastolic flow; PI
1.2.
4. Absent signal: No detectable flow at 40- to 65-mm depths (toward the probe) via transtemporal window (double-checked with insonation from contralateral window across midline at depths of 80 to 100 mm).
Findings Suggesting Flow Diversion in the Anterior
Circulation
1. Flow diversion to ACA or posterior cerebral
artery (PCA) (Figure 2
): Increased
velocities in A1 ACA or P1-P2 PCA segments located at 60- to 74-mm
depths (MFV ACA>MCA or PCA>ACA or PCA>MCA by
10%).
|
2. Flow diversion to perforators: A low-resistance flow at proximal M1 MCA in the presence of abnormal or absent distal M1 or M2 MCA signals.
| Posterior Circulation |
|---|
|
|
|---|
PCA
vertebral artery (VA).
Stenotic Velocities
A focal significant MFV increase >30% compared with proximal
or contralateral arterial segments, and/or PCA MFV
50
cm/sec, BA MFV
60 cm/sec, and VA MFV
50 cm/s in adults.
Abnormal PCA, BA, or VA Waveforms
1. Dampened signal: Pulsatile flow with
normal flow acceleration and decreased MFV (
30% difference between
proximal and distal arterial segments); any PI values.
2. Blunted signal: Arterial flow with
delayed flow acceleration and decreased MFV and positive
end-diastolic flow (low PI
1.1).
3. Minimal signal: Presence of a flow signal directed away from the probe with no end-diastolic flow.
4. Absent signal: No detectable flow at 58- to 70-mm depths for P1-P2 PCA via transtemporal window, no antegrade flow at 75- to 100-mm depths (BA) and 40- to 75-mm depths (VA) via transforaminal window.
Reversed Basilar Artery Flow
Retrograde low- or high-resistance flow identified in the BA
along with abnormal proximal arterial signals indicating
terminal VA or proximal BA obstruction.
Findings Suggesting Flow Diversion in the Posterior
Circulation
Flow diversion to contralateral VA, PICA, or other cerebellar
arteries:
1. Antegrade flow in V4 VA segment located at 40- to 75-mm depths or retrograde flow located at 50 to 70 mm with velocities above age-expected values;
2. Normal or increased velocity in the proximal BA and low-resistance flow in the presence of abnormal distal basilar signals.
| Flow Velocity Asymmetry |
|---|
|
|
|---|
2. Velocity increase in the contralateral hemispheric vessels: Flow velocities above age-expected values, in vessels of the nonaffected side (>20% asymmetry between hemispheres).
3. Velocity increase in the posterior circulation vessels: Flow velocities above age-expected values, in the BA and at least 1 VA (BA>MCA or ICA).
| Collateral Signals |
|---|
|
|
|---|
1.1) unidirectional or
bidirectional flow found at 50- to 60-mm depths
transorbitally;
|
2. No velocity acceleration found in the ICA siphon at 60- to 65-mm depths compared with OA FVs;
3. Siphon flow signals directed away from the probe;
4. Delayed systolic flow acceleration in the siphon compared with the contralateral side.
Anterior Cross-Filling (Figure 4
)
1. Elevated A1 ACA MFVs on the donor side presenting as
ACA>MCA and/or donor ACA MFVs are
1.2 times greater than
contralateral ACA;
|
2. Possible stenotic-like flow at depths of 72 to 78 mm directed away from the donor side;
3. A normal or low MFV in A1 ACA of the recipient side with A1 flow reversal.
PCoA Flow (Figure 5
)
1. A low-resistance flow directed mostly toward the
probe and located posterior to ICA bifurcation (consistently
detected at depths of 58 to 68 mm);
|
2. Velocities equal or greater to that of the M1 MCA.
TCD findings were interpreted by an investigator (A.V.A., A.M.D., or J.C.G.), independent of angiographic findings, following the predefined set of flow parameters presented above. Angiographic investigations included digital subtraction (DSA) in 40% of patients and magnetic resonance (MRA) in 60%. These studies were performed when clinically indicated and interpreted by a neuroradiologist without knowledge of specific TCD flow findings. Angiographic results were used as the gold standard to evaluate specific TCD findings for differentiating each site of arterial occlusion.
| Results |
|---|
|
|
|---|
Angiographic occlusion was seen in 48 patients (including 12 patients with multiple sites of occlusion). There were 17 proximal ICA occlusions, 13 distal ICA occlusions, 17 MCA occlusions, 1 ACA occlusion, 1 PCA occlusion, 9 distal VA occlusions, and 5 BA occlusions. TCD findings in ACA and PCA occlusions were not analyzed because of the small numbers of both types of occlusion.
With proximal ICA occlusion, TCD showed abnormal MCA waveforms (AMCAW)
in 66.7%, reversed OA in 70.6%, anterior cross-filling via the
anterior communicating artery (ACoA) in 78.6%, PCoA in 71.4%, and
contralateral compensatory velocity increase (CVI) in 84.6% of
patients (Tables 1 to 2![]()
). Only 1 of 17 patients with
proximal ICA occlusion had no abnormal TCD findings. With distal ICA
occlusion, TCD showed AMCAW in 88.9%, OA in 16.7%, ACoA in 50%, PCoA
in 60%, and CVI in 88.9% of patients. All 13 patients with distal ICA
occlusion had 1 or more abnormal TCD findings. With MCA occlusion, TCD
showed AMCAW in 100%, OA in 23.5%, ACoA in 31.3%, PCoA in 23.1%,
and CVI in 62.5%. Collaterals were mostly found in patients with
multiple occlusion sites (ie, MCA and ICA). All TCD
parameters listed above were found with patent anterior
vessels in 1.8% to 17.9% (all associations tested separately using a
2x2 matrix
2 analysis,
P
0.003).
|
|
Parameters localizing anterior circulation occlusion were as follows: stenotic terminal ICA velocities 46% versus 10% in patent vessels; flow diversion to perforators 73% versus 1.8%; OA 70.6% versus 5.6%; ACoA 78.6% versus 8.2%; and PCoA 71.4% versus 8.5%, all at P<0.05. A positive trend at P<0.1 was found for the parameters abnormal distal M1-M2 MCA waveforms and flow diversion to ACA.
In patients with BA occlusion, ABAW were found in 80% versus 3% (patent BA); flow diversion to anterior vessels in 60% versus 5.7%; BA flow reversal in 20% versus 0%; and PCoA in 100% versus 13.7%, all at P<0.001. Two of 5 patients with BA occlusion had no abnormal TCD findings except a slight decrease in the distal BA velocities. These patients had distal BA occlusion. All patients with proximal BA occlusion had 1 or more abnormal TCD findings.
TCD findings indicating the presence of a posterior circulation
occlusion were abnormal VA or BA waveforms, flow diversion to
contralateral VA/PICA or anterior circulation vessels, and BA flow
reversal and PCoA flow (all parameters at
P<0.001; Table 3
). No individual flow
parameters differentiated BA from the terminal VA
occlusion. Abnormal BA waveforms and PCoA flow (P<0.20)
were seen more frequently with BA occlusion than VA occlusion; however,
because of the small numbers, there was no statistical difference. The
presence of BA flow reversal was seen in only 1 patient, yet
represented a dramatic sign of proximal basilar
occlusion.
|
| Discussion |
|---|
|
|
|---|
Our study has limitations before it can be extrapolated to the acute stroke setting. We included patients at any time point from symptom onset, thus explaining the relatively low 25% (48/190) incidence of occlusion. When TCD and angiography had been performed within the first few hours of ischemia, the incidence of occlusion was likely to be much higher.12 13 The incidence of arterial occlusion in rtPA-eligible patients on TCD was 69% with sensitivity of 88% compared with angiography.13 Another limitation of any study of this kind is the variable time between TCD and angiography, yet this is commonplace in clinical practice.
Our data show that abnormal MCA, ICA, or posterior circulation waveforms (not just the velocities) are the key parameters to unmask arterial occlusion. Proximal ICA occlusion commonly produces abnormal waveform at the ICA siphon or terminal ICA. Its effect on MCA waveform will largely depend on collateralization of flow and arrival of maximum systolic velocity (flow acceleration). Other findings helpful to indicate arterial occlusion include flow diversion or compensatory velocity increase in branching vessels.
The level of anterior circulation obstruction is confirmed by detection of collateral channels, such as reversed OA or communicating arteries. Occasionally, OA may have no detectable flow or normal flow direction if a distal ICA or MCA occlusion is also present. OA may also have a normal flow direction with proximal ICA occlusion if siphon is filled retrograde via communicating arteries.
Isolated occlusion at the MCA level produces abnormal waveforms without flow collateralization via OA or communicating arteries. If present, these collaterals usually indicate tandem ICA/MCA lesions. TCD detected abnormal MCA waveforms or no signals in all patients with angiographically proved MCA occlusion. The highest sensitivity of TCD with MCA lesions has been established previously.2 5 8 14 Other factors that help to localize MCA occlusion include flow diversion to the ACA, perforators, or PCA. Tandem MCA/ICA occlusion can be diagnosed by detecting abnormal MCA waveform or asonic MCA segment and major collateral channel, which indicate the presence of a proximal lesion in the feeding vessel.
The presence of abnormal VA or BA waveforms should signal the possibility that occlusion of either of these vessels is present. These findings need to be interpreted cautiously and confirmed by identifying flow diversion or compensatory flow increase. Differential diagnosis should include a flow-limiting stenosis and velocity asymmetry due to changes in the insonation angle. TCD accuracy for posterior circulation lesions is lower than for anterior occlusion, and TCD can be used as an adjunct to other vascular imaging tests in patients with vetebrobasilar ischemia.9
In our study the frequency of specific TCD flow findings in patients with no arterial occlusion was low (0% to 17.9%). Such findings as stenotic velocities and flow velocity increase can be found in 12.5% to 17.9% of patients with no occlusion. These findings are mostly attributable to stenotic lesions or velocity asymmetry and should not be overinterpreted without abnormal waveforms and evidence of flow collateralization. The frequency of abnormal waveforms in patients with no occlusion was 1.8% to 6.6%, which indicates that if TCD findings are normal there is a >90% chance that angiography will show no proximal arterial obstruction.8 10 Although MRA had 100% sensitivity and 95% specificity for intracranial occlusion in 1 study,15 its overall accuracy is limited compared with DSA due to appearance of flow gaps with critical stenoses and difficulties in differentiating slow flow from occlusion. Nevertheless, in clinical practice TCD is often compared with MRA for the presence of these lesions. Our results indicate that an acceptable agreement between these modalities can be achieved.
A better understanding of the specific flow findings is a key step in clinical acceptance of this modality, because these findings can broaden diagnostic batteries for TCD. An experienced TCD user can rapidly identify patients with M1 MCA occlusion with sensitivity and specificity exceeding 90%. With these accuracy parameters, TCD screening can help to reduce the number of negative invasive angiograms.10 13 14 In the Prolyse in Acute Cerebral Thrombo-embolism Trial (PROACT),16 12 323 patients were evaluated clinically and with non-contrast CT scan to identify MCA occlusion. This method of screening led to 476 angiograms (26:1 ratio), of which only 180 were found to indicate M1-M2 MCA occlusions (2.6:1 ratio). Other applications of TCD, such as monitoring reperfusion during thrombolysis,17 18 deserve further study.
In conclusion, specific TCD findings are common with major arterial occlusion and can be used to broaden diagnostic batteries and improve the predictive value of this noninvasive screening tool. TCD findings useful to localize anterior circulation occlusion include collaterals, abnormal waveforms or velocities, and flow diversion to perforators.
| Acknowledgments |
|---|
Received July 27, 1999; revision received September 29, 1999; accepted September 29, 1999.
| References |
|---|
|
|
|---|
2.
Lindegaard K-F, Bakke SJ, Aaslid R, Nornes H.
Doppler diagnosis of intracranial occlusive disorders. J
Neurol Neurosurg Psychiatry. 1986;49:510518.
3. Hennerici MD, Rautenberg W, Schwartz A. Transcranial Doppler ultrasound for the assessment of intracranial arterial flow velocity, part 2: evaluation of intracranial arterial disease. Surg Neurol. 1987;27:523532.[Medline] [Order article via Infotrieve]
4.
Grolimund P, Seiler RW, Aaslid R, Huber P,
Zurbruegg H. Evaluation of cerebrovascular disease by combined
extracranial and transcranial Doppler sonography:
experience in 1,039 patients. Stroke. 1987;18:10181024.
5. Mattle H, Grolimund P, Huber P, Sturzenegger M, Zurbrugg HR. Transcranial Doppler sonographic findings in middle cerebral artery disease. Arch Neurol. 1988;289295.
6.
Wilterdink JL, Feldmann E, Furie KL, Bragoni M,
Benavides JG. Transcranial Doppler ultrasound battery
reliably identifies severe internal carotid artery stenosis.
Stroke. 1997;28:133136.
7.
Kaps M, Damian MS, Teschendorf U, Dorndorf W.
Transcranial Doppler ultrasound findings in middle
cerebral artery occlusion. Stroke. 1990;21:532537.
8. Babikian V, Sloan MA, Tegeler CH, DeWitt LD, Fayad PB, Feldmann E, Gomez CR. Transcranial Doppler validation pilot study. J Neuroimaging. 1993;3:242249.[Medline] [Order article via Infotrieve]
9.
Brandt T, Knauth M, Wildermuth S, Winter R, von Kummer
R, Sartor K, Hacke W. CT angiography and Doppler sonography for
emergency assessment in acute basilar artery ischemia.
Stroke. 1999;30:606612.
10. Demchuk AM, Christou I, Wein TH, Felberg RA, Malkoff M, Grotta JC, Alexandrov AV. The accuracy and differential diagnosis of arterial occlusion with transcranial Doppler. J Neuroimaging. 1999;9:57. Abstract.
11. Alexandrov AV. Transcranial Doppler sonography: principles, examination technique, normal values, and waveform patterns. Vasc Ultrasound Today. 1998;3:141160.
12. Fieschi C, Argentino C, Lenzi GL, Sacchetti ML, Toni D, Bozzao L. Clinical and instrumental evaluation of patients with ischemic stroke within six hours. J Neurol Sci. 1989;91:311322.[Medline] [Order article via Infotrieve]
13.
Alexandrov AV, Demchuk AM, Wein TH, Grotta JC. The
yield of transcranial Doppler in acute cerebral
ischemia. Stroke. 1999;30:16041609.
14.
Zanette EM, Fieschi C, Bozzao L, Roberti C, Toni D,
Argentino C, Lenzi GL. Comparison of cerebral angiography and
transcranial Doppler sonography in acute stroke.
Stroke. 1989;20:899903.
15.
Stock KW, Radue EW, Jacob AL, Bao XS, Steinbrich W.
Intracranial arteries: prospective blinded comparative study of MR
angiography and DSA in 50 patients. Radiology. 1995;195:451456.
16. Furlan AJ, Higashida RT, Wechsler LR, and PROACT II Investigators. PROACT II: Recombinant Prourokinase (r-ProUK) in acute cerebral thromboembolism: initial trial results. In: Highlights, 24th AHA International Conference on Stroke and Cerebral Circulation[program and abstracts on CD-ROM]. Dallas, Tex: American Heart Association; 1999.
17. Kaps M, Link A. Transcranial sonographic monitoring during thrombolytic therapy. AJNR Am J Neuroradiol. 1998;19:758760.[Abstract]
18.
Demchuk AM, Felberg RA, Alexandrov AV. Clinical
recovery from acute ischemic stroke after early reperfusion of
the brain with intravenous thrombolysis.
N Engl J Med. 1999;340:894895.
Letter.
This article has been cited by other articles:
![]() |
A. V. Alexandrov, H. T. Nguyen, M. Rubiera, A. W. Alexandrov, L. Zhao, I. Heliopoulos, A. Robinson, J. DeWolfe, and G. Tsivgoulis Prevalence and Risk Factors Associated With Reversed Robin Hood Syndrome in Acute Ischemic Stroke Stroke, August 1, 2009; 40(8): 2738 - 2742. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Saqqur, G. Tsivgoulis, C. A. Molina, A. M. Demchuk, M. Siddiqui, J. Alvarez-Sabin, K. Uchino, S. Calleja, A. V. Alexandrov, and For the CLOTBUST Investigators Symptomatic intracerebral hemorrhage and recanalization after IV rt-PA: A multicenter study Neurology, October 21, 2008; 71(17): 1304 - 1312. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Alexandrov, R. Mikulik, M. Ribo, V. K. Sharma, A. Y. Lao, G. Tsivgoulis, R. M. Sugg, A. Barreto, P. Sierzenski, M. D. Malkoff, et al. A Pilot Randomized Clinical Safety Study of Sonothrombolysis Augmentation With Ultrasound-Activated Perflutren-Lipid Microspheres for Acute Ischemic Stroke Stroke, May 1, 2008; 39(5): 1464 - 1469. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. K. Sharma, G. Tsivgoulis, A. Y. Lao, M. D. Malkoff, and A. V. Alexandrov Noninvasive Detection of Diffuse Intracranial Disease Stroke, December 1, 2007; 38(12): 3175 - 3181. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. N. Popa, M. P. Spencer, C. L. Lion, and R. A. Felberg Power M-Mode Doppler and Single-Gate Spectral Analysis Using a 2-MHz Pulsed-Wave Doppler Transducer to Directly Detect Cervical Internal Carotid Artery Stenosis: Use of the Continuity Principle: Report of a Novel Technique Stroke, June 1, 2007; 38(6): 1780 - 1785. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Saqqur, K. Uchino, A. M. Demchuk, C. A. Molina, Z. Garami, S. Calleja, N. Akhtar, F. O. Orouk, A. Salam, A. Shuaib, et al. Site of Arterial Occlusion Identified by Transcranial Doppler Predicts the Response to Intravenous Thrombolysis for Stroke Stroke, March 1, 2007; 38(3): 948 - 954. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Saqqur, C. A. Molina, A. Salam, M. Siddiqui, M. Ribo, K. Uchino, S. Calleja, Z. Garami, K. Khan, N. Akhtar, et al. Clinical Deterioration After Intravenous Recombinant Tissue Plasminogen Activator Treatment: A Multicenter Transcranial Doppler Study Stroke, January 1, 2007; 38(1): 69 - 74. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ribo, J. Alvarez-Sabin, J. Montaner, F. Romero, P. Delgado, M. Rubiera, R. Delgado-Mederos, and C. A. Molina Temporal Profile of Recanalization After Intravenous Tissue Plasminogen Activator: Selecting Patients for Rescue Reperfusion Techniques Stroke, April 1, 2006; 37(4): 1000 - 1004. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. I. Savitz, G. Schlaug, L. Caplan, and M. Selim Arterial Occlusive Lesions Recanalize More Frequently in Women Than in Men After Intravenous Tissue Plasminogen Activator Administration for Acute Stroke Stroke, July 1, 2005; 36(7): 1447 - 1451. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Alexandrov Ultrasound Identification and Lysis of Clots Stroke, November 1, 2004; 35(11_suppl_1): 2722 - 2725. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Linfante, R. H. Llinas, M. Selim, C. Chaves, S. Kumar, R. A. Parker, L. R. Caplan, and G. Schlaug Clinical and Vascular Outcome in Internal Carotid Artery Versus Middle Cerebral Artery Occlusions After Intravenous Tissue Plasminogen Activator Stroke, August 1, 2002; 33(8): 2066 - 2071. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Akopov and G.T. Whitman Hemodynamic Studies in Early Ischemic Stroke: Serial Transcranial Doppler and Magnetic Resonance Angiography Evaluation Stroke, May 1, 2002; 33(5): 1274 - 1279. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Ezzeddine, M. H. Lev, C. T. McDonald, G. Rordorf, J. Oliveira-Filho, F. G. Aksoy, J. Farkas, A. Z. Segal, L. H. Schwamm, R. G. Gonzalez, et al. CT Angiography With Whole Brain Perfused Blood Volume Imaging: Added Clinical Value in the Assessment of Acute Stroke Stroke, April 1, 2002; 33(4): 959 - 966. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Baracchini, R. Manara, M. Ermani, and G. Meneghetti The Quest for Early Predictors of Stroke Evolution : Can TCD Be a Guiding Light? Stroke, December 1, 2000; 31(12): 2942 - 2947. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |